Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

about

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

Item

http://www.wikidata.org/entity/Q43038588

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

@en

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

@nl

type

Item

label

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

@en

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

@nl

prefLabel

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

@en

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

@nl

P1476

Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.

@en

P2093

Anna Boroń-Kaczmarska

http://www.w3.org/2001/XMLSchema#string

Ewa Karpińska

http://www.w3.org/2001/XMLSchema#string

Ewelina Herman

http://www.w3.org/2001/XMLSchema#string

Jerzy Lubikowski

http://www.w3.org/2001/XMLSchema#string

Krzysztof Jurczyk

http://www.w3.org/2001/XMLSchema#string

Marta Wawrzynowicz-Syczewska

http://www.w3.org/2001/XMLSchema#string

Łukasz Laurans

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of immunosuppressive therapy on recurrence of hepatitis C.

Specific inhibition of hepatitis C virus replication by cyclosporin A.

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.

Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.

Cholestatic hepatitis C in liver allografts.

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine.

12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.

P304

808-810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1432-2277.2007.00508.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6259627

http://www.w3.org/2001/XMLSchema#string

P698

17578456

http://www.w3.org/2001/XMLSchema#string